<DOC>
	<DOCNO>NCT01350440</DOCNO>
	<brief_summary>This preliminary study determine safety efficacy intravenous immune globulin treat Spinocerebellar Ataxia . The investigator aim assess change clinical measure disease severity treatment .</brief_summary>
	<brief_title>Safety Efficacy Intravenous Immune Globulin Treating Spinocerebellar Ataxia</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Spinocerebellar Ataxias</mesh_term>
	<mesh_term>Spinocerebellar Degenerations</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>1 . Outpatients SCA diagnose movement disorder specialist . 2 . Age 10 year 80 year . 3 . Able ambulate without assistance 30 foot . 4 . Women childbearing potential must use reliable method contraception must provide negative pregnancy test entry study . 5 . Serum creatine kinase , complete metabolic panel , complete blood count , liver function test , renal function test , platelet EKG reveal clinically significant abnormality ( result obtain primary care physician date within past 6 month obtain screen visit ) . 6 . Stable dos medication 30 day prior study entry duration study . 7 . Stable dos antidepressant vitamin ( include internet purchase idebenone ) 30 day prior study entry duration study . Throughout study , possible effort make maintain stable dos medication . 8 . Subject permission ( informed consent ) . 1 . Any unstable illness investigator 's opinion precludes participation study . 2 . Use investigational product within past 30 day . 3 . Presence clinically significant cardiac disease ( determine investigator base EKG echocardiogram result within past 6 month ) . Specifically , ejection fraction &lt; 40 % , prolonged QT interval ( &gt; 50 % cycle duration ) exclude . If investigator note clinically significant abnormality EKG echocardiogram , subject eligible IF provide clearance cardiologist . 4 . Presence diabetes ( determine blood glucose lab within past 6 month ) . 5 . Dementia psychiatric illness prevents subject give informed consent ( MMSE less 25 ) . 6 . Legal incapacity limit legal capacity . 7 . Presence severe renal disease ( estimate creatinine clearance &lt; 50 mL/min ) hepatic disease ( AST ALT &gt; 2x time normal ) ( evidence lab report within past 6 month ) . 8 . Clinically significantly abnormal WBC , hemoglobin platelet count ( evidence lab report within past 6 month ) . 9 . IgA deficiency ( evidenced screening lab evaluation )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>